mRNA COVID-19 Vaccination Does Not Exacerbate Symptoms or Trigger Neural Antibody Responses in Multiple Sclerosis.
Yolanda BlancoDomingo EscuderoCinta LleixàSara LlufriuNatalia EgriRaquel Ruiz GarcíaMercedes AlbaEsther AguilarMontse ArtolaMarta Aldea NovoSilvia AlvarezEva CaballeroJose Maria Cabrera-MaquedaElianet FonsecaMar GuaspAna HernandoEugenia Martinez-HernandezGemma Olivé-CireraJoaquín López-ContrerasLorena Martín-AguilarLaura Martinez-MartinezAlexander RombautsMaria RodésLidia SabaterMaria SepúlvedaElisabeth SolanaClara Tejada-IllaNuria Vidal-FernándezAnna VilellaClaudia FortunyThaís ArmangueJosep O DalmauLuis Antonio Querol-GutiérrezAlbert SaizPublished in: Neurology(R) neuroimmunology & neuroinflammation (2023)
In this study, mRNA COVID-19 vaccination was safe and did not exacerbate the autoimmune disease nor triggered neural autoantibodies or immune-mediated neurologic disorders. The outcome of patients who developed SARS-CoV-2 infection was favorable.